Compare HCA Health Inc (HCA) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Visa Inc — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Visa Inc trades at $375.22 (market cap $698.56B). The key difference: Visa Inc is far larger — about 7.3× HCA Health Inc's market cap, and Visa Inc pays the higher dividend (0.72%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Visa Inc for 115 Days on average.
| HCA | V | |
|---|---|---|
Market Cap | $95.08B | $698.56B |
Volume | 998,787 | 4,446,146 |
Sector | Health | Financials |
52-Week High | $545.13 | $384.14 |
52-Week Low | $361.32 | $295.52 |
Typical Hold Time | 76 Days | 115 Days |
Enterprise Value | $145.62B | $709.14B |
Dividend Yield | 0.71% | 0.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Visa (V) trades at $372.10, up 0.39% with a bullish technical outlook. The stock shows strong fundamentals with 85% analyst buy ratings and a $422.24 consensus price target, representing 13.5% upside. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $3.32 exceeding the $3.23 forecast. The company maintains exceptional profitability with 50.78% net margins and 61.79% ROE, while expanding AI-driven commerce initiatives through new partnerships and technology platforms.
Visa presents a compelling long-term investment case with dominant market position, consistent earnings growth, and strategic AI integration. Key risks include regulatory pressures, fintech competition, and stablecoin disruption potential. The current valuation at 31.67x P/E reflects premium pricing but is supported by strong growth prospects and defensive cash flow characteristics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
